Colorectal CancerNCT05353127
Cardiopulmonary Exercise Test Data Averaging Methods and Preoperative Risk Assessment
An observational study of Colorectal Cancer and Surgery, run by VieCuri Medical Centre at 1 site in Netherlands.
Trial summary
Cardiopulmonary exercise testing (CPET) is used for preoperative risk assessment in patients with colorectal cancer who need to undergo surgery. For presentation and interpretation purposes, CPET data are averaged by using a time- or breath-based average. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Colorectal Cancer, Surgery, Colorectal Neoplasms Malignant
- What is being tested?
- CPET/Cardiopulmonary Exercise Test
- How many people
- 21 participants
- Where
- 1 siteNetherlands
- Study dates
- 12 Apr 2022to 1 Oct 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Patients considered for colorectal cancer surgery at the VieCuri Medical Centre Venlo, who had undergone a preoperative CPET before colorectal surgery as a part of a prehabilitation study.
Who may be able to join
- Patiënts with colorectal cancer, considered for surgery.
- A score of ≤7 metabolic equivalents of task on the veterans-specific activity questionnaire and therefore performed preoperative CPET as a part of a prehabilitation study
Who cannot join
- Patiënt unable to perform CPET.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Influence of Different Data Averaging Methods on Preoperative Risk Assessment Using Cardiopulmonary Exercise Testing in Patients Scheduled for Colorectal Surgery
Cardiopulmonary exercise testing (CPET) is used for preoperative risk assessment in patients with colorectal cancer who need to undergo surgery. For presentation and interpretation purposes, CPET data are averaged by using a time- or breath-based average. It is uncertain to what extent differences in data averaging methods influence the numerical value of preoperative CPET-derived variables used for risk assessment. Therefore, the primary aim of this study is to investigate the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables used for preoperative risk assessment in patients scheduled for elective colorectal cancer surgery. The secondary aim is to elucidate the impact of data-averaging intervals on classification of patients into a low- or high-risk category for postoperative complications based on known risk assessment thresholds.
Read the detailed description
Surgery for colorectal cancer is associated with a high incidence of postoperative complications. Risk assessment by means of a cardiopulmonary exercise test (CPET) is an essential part of the preoperative diagnostic work-up of colorectal cancer patients. During CPET, a patient exercises against a progressively increasing work rate until volitional exhaustion, while breath-by-breath respiratory gasses are analyzed. The large number of data points that are collected by the breath-by-breath sampling rate can be a burden for data visualization, as they can be noisy. Therefore, data averaging is performed to optimize graphical data display and to aid CPET interpretation. To date, there are no studies quantifying the extent to which differences in data averaging influence the numerical value of preoperative CPET-derived variables for risk assessment based on aerobic fitness, such as the the oxygen uptake (VO2) at the ventilatory anaerobic threshold (VAT), VO2 at peak exercise (VO2peak), and the oxygen uptake efficiency slope (OUES), and of preoperative CPET-derived variables for risk assessment based on ventilatory efficiency, such as the ventilatory equivalent for carbon dioxide production at the VAT (VE/VCO2VAT) and the slope of the relationship between the minute ventilation and carbon dioxide production (VE/VCO2-slope). Therefore, the primary aim of this study is to investigate the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables used for preoperative risk assessment in patients scheduled for elective colorectal cancer surgery. The secondary aim is to elucidate the impact of data-averaging intervals on the classification of patients into a low- or high-risk category for postoperative complications based on known risk assessment thresholds.
Participants Data from patients considered for colorectal cancer surgery who are ≥18 years of age, have a score ≤7 metabolic equivalents of task on the veterans-specific activity questionnaire, and therefore performed preoperative CPET as a part of a prehabilitation study will be collected. Preoperative CPET was conducted before any intervention was initiated.
Procedures Preoperative CPET data will be anonymized and patient characteristics other than anthropometric measures will be concealed. A medical physiologist and a clinical exercise physiologist will determine the CPET variables VO2VAT, VO2peak, respiratory exchange ratio at peak exercise (RERpeak), VE/VCO2VAT, VE/VCO2-slope, and the OUES in all 20 CPETs using a predefined set of guidelines Final determination of each parameter will be based on consensus between the two observers. In case of disagreement between observers, a third observer will be consulted. Determination of the aforementioned CPET variables will be repeated using each of the five different data-averaging intervals. Data averaging-intervals consists of a stationary time-based average over 10, 20, and 30 seconds, and of a rolling average over 3 and 7 breaths that were defined as follows. The stationary time-based average will be calculated by averaging the breath-by-breath data over 10, 20, or 30 seconds. A rolling average is defined as averaging a fixed number of single breath measurements (i.e., 3 and 7), then discarding the first breath and adding a new breath to obtain a new breath averaging block.
CPET interpretation will be performed using Blue Cherry software version 1.3.3.3 (Geratherm Respiratory GmbH, Bad Kissingen, Germany).
Apart from the CPET data, the preoperative patient characteristics age, sex, body mass index, smoking status (never, former, current), age-adjusted Charlson comorbidity index, comorbidities, American Society of Anesthesiologists classification, veterans-specific activity questionnaire score, hemoglobin levels (mmol/L), and tumor location will be recorded.
To assess the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables, mean differences of the numerical values of VO2VAT, VO2peak, RERpeak, VE/VCO2VAT, VE/VCO2-slope, and OUES between different data-averaging intervals will be analyzed by means of within factors repeated measures analysis of variance (ANOVA). In case of a statistically significant difference between methods (p<0.05), post-hoc testing will be performed using the Bonferroni test to identify the exact differences. To evaluate the influence of data-averaging intervals on risk assessment, participants will be classified as being at low or high risk for postoperative complications based on their VO2VAT, VO2peak, VE/VCO2VAT, and OUES. For each CPET-derived variable, numerical values will be determined for each of the five data-averaging will be compared with known preoperative risk assessment thresholds (patients will be classified as high-risk when having a VO2VAT <11.1 mL/kg/min, a VO2peak <18.2 mL/kg/min, a VE/VCO2VAT >30.9, and/or an OUES/kg <20.6). Friedman's test will be used to determine whether differences in risk assessment exist between data-averaging methods. Differences between data-averaging methods will be assumed statistically significant when p<0.05.
- Conditions
- Colorectal Cancer, Surgery, Colorectal Neoplasms Malignant
- Being tested
- CPET/Cardiopulmonary Exercise Test
- Keywords
- colorectal surgery, Prehabilitation, CPET, CardioPulmonary Exercise Testing
- Medical subject headings
- Colorectal Neoplasms, Colonic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CPET/Cardiopulmonary Exercise TestDiagnostic test
During CPET, a patient exercises against a progressively increasing work rate until volitional exhaustion, while breath-by-breath respiratory gasses are analyzed.
| Study group | Role | What they receive |
|---|---|---|
| Patiënts who underwent a CPET prior to elective colorectal surgery investigate fitness level. | Patients considered for colorectal cancer surgery who were ≥18 years of age, had a score ≤7 metabolic equivalents of task on the veterans-specific activity questionnaire. Receives: Diagnostic Test: CPET/Cardiopulmonary Exercise Test |
What is being measured
The primary outcome is the main question the study is designed to answer.
Influence of different CPET data averaging intervals on the numerical values of CPET-derived variables.
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VO2VAT,
Measured: Baseline, pre surgery
Influence of different CPET data averaging intervals on the numerical values of CPET-
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VO2peak.
Measured: Baseline, pre surgery
Influence of different CPET data averaging intervals on the numerical values of CPET-
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VE/VCO2-slope.
Measured: Baseline, pre surgery
Influence of different CPET data averaging intervals on the numerical values of CPET-
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of RERpeak.
Measured: Baseline, pre surgery
Influence of different CPET data averaging intervals on the numerical values of CPET-
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VE/VCO2VAT.
Measured: Baseline, pre surgery
Influence of different CPET data averaging intervals on the numerical values of CPET-
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of the OUES.
Measured: Baseline, pre surgery
Secondary outcomes (1)
High- or Low-risk for postoperative complications
Patients are classified as high-risk when having a VO2VAT <11.1 mL/kg/min, a VO2peak <18.2 mL/kg/min, a VE/VCO2VAT >30.9 [12], and/or an OUES/kg <20.6
Measured: Baseline, pre surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Apr 2022
- Study start12 Apr 2022
- Primary completion1 Sep 2022
- Study completion1 Oct 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Colorectal CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 21 participants (actual)
Sponsor and investigators
- Lead sponsor
- VieCuri Medical Centre
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05353127
- Sponsor's protocol ID
- 2022_053
- Status last verified
- Apr 2022
- First submitted
- 8 Apr 2022
- Last updated
- 23 Nov 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Franssen RFW, Sanders BHE, Takken T, Vogelaar FJ, Janssen-Heijnen MLG, Bongers BC. Influence of different data-averaging methods on mean values of selected variables derived from preoperative cardiopulmonary exercise testing in patients scheduled for colorectal surgery. PLoS One. 2023 Mar 16;18(3):e0283129. doi: 10.1371/journal.pone.0283129. eCollection 2023.
PubMed 36928094
Study at a glance
From the registry record, last updated by the sponsor on 23 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Influence of Different Data Averaging Methods on Preoperative Risk Assessment Using Cardiopulmonary Exercise Testing in Patients Scheduled for Colorectal Surgery
- ClinicalTrials.gov ID
- NCT05353127
- Acronym / sponsor ID
- 2022_053
- Conditions
- Colorectal Cancer, Surgery, Colorectal Neoplasms Malignant
- Keywords
- colorectal surgery, Prehabilitation, CPET, CardioPulmonary Exercise Testing
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 21 participants (actual)
- Lead sponsor
- VieCuri Medical CentreUniversity, hospital or other
- Study start
- 12 Apr 2022 (actual)
- Primary completion
- 1 Sep 2022 (actual)
- Study completion
- 1 Oct 2022 (actual)
- First posted
- 29 Apr 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cardiopulmonary exercise testing (CPET) is used for preoperative risk assessment in patients with colorectal cancer who need to undergo surgery. For presentation and interpretation purposes, CPET data are averaged by using a time- or breath-based average. It is uncertain to what extent differences in data averaging methods influence the numerical value of preoperative CPET-derived variables used for risk assessment. Therefore, the primary aim of this study is to investigate the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables used for preoperative risk assessment in patients scheduled for elective colorectal cancer surgery. The secondary aim is to elucidate the impact of data-averaging intervals on classification of patients into a low- or high-risk category for postoperative complications based on known risk assessment thresholds.
Detailed description
Surgery for colorectal cancer is associated with a high incidence of postoperative complications. Risk assessment by means of a cardiopulmonary exercise test (CPET) is an essential part of the preoperative diagnostic work-up of colorectal cancer patients. During CPET, a patient exercises against a progressively increasing work rate until volitional exhaustion, while breath-by-breath respiratory gasses are analyzed. The large number of data points that are collected by the breath-by-breath sampling rate can be a burden for data visualization, as they can be noisy. Therefore, data averaging is performed to optimize graphical data display and to aid CPET interpretation. To date, there are no studies quantifying the extent to which differences in data averaging influence the numerical value of preoperative CPET-derived variables for risk assessment based on aerobic fitness, such as the the oxygen uptake (VO2) at the ventilatory anaerobic threshold (VAT), VO2 at peak exercise (VO2peak), and the oxygen uptake efficiency slope (OUES), and of preoperative CPET-derived variables for risk assessment based on ventilatory efficiency, such as the ventilatory equivalent for carbon dioxide production at the VAT (VE/VCO2VAT) and the slope of the relationship between the minute ventilation and carbon dioxide production (VE/VCO2-slope). Therefore, the primary aim of this study is to investigate the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables used for preoperative risk assessment in patients scheduled for elective colorectal cancer surgery. The secondary aim is to elucidate the impact of data-averaging intervals on the classification of patients into a low- or high-risk category for postoperative complications based on known risk assessment thresholds.
Participants Data from patients considered for colorectal cancer surgery who are ≥18 years of age, have a score ≤7 metabolic equivalents of task on the veterans-specific activity questionnaire, and therefore performed preoperative CPET as a part of a prehabilitation study will be collected. Preoperative CPET was conducted before any intervention was initiated.
Procedures Preoperative CPET data will be anonymized and patient characteristics other than anthropometric measures will be concealed. A medical physiologist and a clinical exercise physiologist will determine the CPET variables VO2VAT, VO2peak, respiratory exchange ratio at peak exercise (RERpeak), VE/VCO2VAT, VE/VCO2-slope, and the OUES in all 20 CPETs using a predefined set of guidelines Final determination of each parameter will be based on consensus between the two observers. In case of disagreement between observers, a third observer will be consulted. Determination of the aforementioned CPET variables will be repeated using each of the five different data-averaging intervals. Data averaging-intervals consists of a stationary time-based average over 10, 20, and 30 seconds, and of a rolling average over 3 and 7 breaths that were defined as follows. The stationary time-based average will be calculated by averaging the breath-by-breath data over 10, 20, or 30 seconds. A rolling average is defined as averaging a fixed number of single breath measurements (i.e., 3 and 7), then discarding the first breath and adding a new breath to obtain a new breath averaging block.
CPET interpretation will be performed using Blue Cherry software version 1.3.3.3 (Geratherm Respiratory GmbH, Bad Kissingen, Germany).
Apart from the CPET data, the preoperative patient characteristics age, sex, body mass index, smoking status (never, former, current), age-adjusted Charlson comorbidity index, comorbidities, American Society of Anesthesiologists classification, veterans-specific activity questionnaire score, hemoglobin levels (mmol/L), and tumor location will be recorded.
To assess the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables, mean differences of the numerical values of VO2VAT, VO2peak, RERpeak, VE/VCO2VAT, VE/VCO2-slope, and OUES between different data-averaging intervals will be analyzed by means of within factors repeated measures analysis of variance (ANOVA). In case of a statistically significant difference between methods (p<0.05), post-hoc testing will be performed using the Bonferroni test to identify the exact differences. To evaluate the influence of data-averaging intervals on risk assessment, participants will be classified as being at low or high risk for postoperative complications based on their VO2VAT, VO2peak, VE/VCO2VAT, and OUES. For each CPET-derived variable, numerical values will be determined for each of the five data-averaging will be compared with known preoperative risk assessment thresholds (patients will be classified as high-risk when having a VO2VAT <11.1 mL/kg/min, a VO2peak <18.2 mL/kg/min, a VE/VCO2VAT >30.9, and/or an OUES/kg <20.6). Friedman's test will be used to determine whether differences in risk assessment exist between data-averaging methods. Differences between data-averaging methods will be assumed statistically significant when p<0.05.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patiënts who underwent a CPET prior to elective colorectal surgery investigate fitness level. | – | Diagnostic Test: CPET/Cardiopulmonary Exercise TestPatients considered for colorectal cancer surgery who were ≥18 years of age, had a score ≤7 metabolic equivalents of task on the veterans-specific activity questionnaire. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Patients considered for colorectal cancer surgery at the VieCuri Medical Centre Venlo, who had undergone a preoperative CPET before colorectal surgery as a part of a prehabilitation study.
Key inclusion criteria (2 listed)
- Patiënts with colorectal cancer, considered for surgery.
- A score of ≤7 metabolic equivalents of task on the veterans-specific activity questionnaire and therefore performed preoperative CPET as a part of a prehabilitation study
Key exclusion criteria (1 listed)
- Patiënt unable to perform CPET.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CPET/Cardiopulmonary Exercise TestDuring CPET, a patient exercises against a progressively increasing work rate until volitional exhaustion, while breath-by-breath respiratory gasses are analyzed. | Diagnostic test | Patiënts who underwent a CPET prior to elective colorectal surgery investigate fitness level. |
Primary outcome
Influence of different CPET data averaging intervals on the numerical values of CPET-derived variables.
Time frame: Baseline, pre surgery
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VO2VAT,
Influence of different CPET data averaging intervals on the numerical values of CPET-
Time frame: Baseline, pre surgery
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VO2peak.
Influence of different CPET data averaging intervals on the numerical values of CPET-
Time frame: Baseline, pre surgery
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VE/VCO2-slope.
Influence of different CPET data averaging intervals on the numerical values of CPET-
Time frame: Baseline, pre surgery
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of RERpeak.
Influence of different CPET data averaging intervals on the numerical values of CPET-
Time frame: Baseline, pre surgery
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VE/VCO2VAT.
Influence of different CPET data averaging intervals on the numerical values of CPET-
Time frame: Baseline, pre surgery
To assess the influence of different CPET data averaging intervals on the numerical the numerical values of the OUES.
1 secondary outcome
High- or Low-risk for postoperative complications
Time frame: Baseline, pre surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Nov 2022.
- Derived from this study: PubMed 36928094Franssen RFW, Sanders BHE, Takken T, Vogelaar FJ, Janssen-Heijnen MLG, Bongers BC. Influence of different data-averaging methods on mean values of selected variables derived from preoperative cardiopulmonary exercise testing in patients scheduled for colorectal surgery. PLoS One. 2023 Mar 16;18(3):e0283129. doi: 10.1371/journal.pone.0283129. eCollection 2023.
- Individual participant dataSharing planned: Undecided
Related trials for Colorectal Cancer
Active, not recruitingObservational study
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
Prostate Cancer, BRCA Mutation
RecruitingPhase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Advanced Solid Tumors, Metastatic Pancreatic Cancer
Active, not recruitingPhase 1/2
A Beta-only IL-2 ImmunoTherapY Study
Advanced Solid Tumor, Unresectable Solid Tumor
RecruitingPhase 1/2
LYL273 for Patients With Relapsed or Refractory mCRC
Colorectal Cancer
RecruitingPhase 1
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Metastatic Colorectal Adenocarcinoma, Recurrent Colorectal Adenocarcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colorectal Cancer and Surgery, run by VieCuri Medical Centre at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Influence of different CPET data averaging intervals on the numerical values of CPET-derived variables. (time frame: Baseline, pre surgery). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05353127, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Nov 2022; AzTrials last refreshed its copy on 31 Oct 2026.